Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06754657

CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery

The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery.

The participants will:

* Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump. * Be monitored via telephone by the research team to complete the QoR-15 survey, assess pain levels, the need for tramadol use, and any complications. * Have follow-up by the Acute Pain Unit during the first 3 days.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Red de Salud UC Christus

Santiago, 8330024, Chile

Location status: Recruiting

Location contact

Victor Contreras, MSN

CONTACT

[email protected]

56981895232

About this study

After obtaining approval from the institutional CEC-CCSS and prospective registration of the study at clinicaltrials.org, the investigators will recruit patients who meet the inclusion criteria and provide written consent.

Following surgery and placement of the interscalene block with a catheter, in the recovery unit, participants will be assigned to one of two groups according to a random number table, in a 1:1 ratio using block randomization (block sizes of 4, 6, and 8) through sealed envelopes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (≥18 years, < 75 years) scheduled for elective outpatient arthroscopic rotator cuff repair surgery.
  • Patients capable of managing a continuous outpatient regional analgesia system based on an interscalene block (eligibility criteria: able to understand verbal and written instructions, have home support, and live geographically close to the healthcare center).
  • Willing and able to provide informed, written consent to participate in the study.

Exclusion criteria

  • History of chronic opioid use (>3 months).
  • Severe comorbidities (e.g., renal or hepatic failure, ASA classification of 3 or higher).
  • Allergy to local anesthetics, dexamethasone, or the analgesic drugs used in the study.
  • Patients with contraindications for peripheral nerve block.

Treatment and study plan

Continuous perineural infusion

Procedure

infusion rate 4 ml/h, with 5 ml boluses (30-minute lockout). The PCA button disabled

Single injection

Procedure

infusion rate 0 ml/h, with 5 ml boluses (30-minute lockout). The PCA button will be enabled for rescue bolus administration

Primary outcomes

  1. Daily score on the "Quality of Recovery-15" (QoR-15) scale during the first 3 postoperative days.

    Time frame: Preoperative score and daily score during the first 3 postoperative days.

    The QoR-15 is a validated instrument in the literature that assesses the quality of recovery in patients after surgery. It is a multidimensional measurement tool that allows healthcare professionals to gain an overview of the patient's well-being during the postoperative period. The questionnaire consists of 15 items, covering 5 dimensions: Physical Comfort, Physical Independence, Emotional Support, Psychological Well-being, and Satisfaction with Recovery. The minimum score on the scale is 0 points, and the maximum score is 150 points. This range is obtained by summing the scores of the different categories evaluated in the QoR-15 scale, where a higher score indicates a better quality of postoperative recovery.

Secondary outcomes

  1. Opioid consumption during the first 3 postoperative days

    Time frame: Daily consumption during the first 3 postoperative days.

    To assess rescue opioid consumption, expressed as morphine equivalents, during the first three postoperative days.

  2. Daily Numeric Rating Score (NRS) during the first 3 postoperative days

    Time frame: Daily NRS during the first 3 postoperative days

    The NRS (Numeric Rating Scale) is commonly used to assess pain intensity. Its minimum score is 0, indicating no pain, and its maximum score is 10, indicating the worst pain imaginable. This scale is simple and allows patients to rate their pain using a number from 0 to 10. The objective is to assess the intensity of acute postoperative pain, expressed as NRS, during the first 3 postoperative days.

  3. Rate of consultations/readmissions

    Time frame: During the first 3 postoperative days

    To assess the rate of consultations or readmissions due to pain or other complications in both groups.

  4. Rate of rescue analgesic (bolus) during the first 3 postoperative days

    Time frame: During the first 3 postoperative days

    In the case that patients do not experience pain relief with the established management, as indicated by persistent NRS ≥ 4 after the administration of more than two rescue tramadol tablets, they will be instructed to call the contact phone number of the Ambulatory Pain Management Unit to receive guidance on how to implement a rescue bolus using the perineural catheter and the bolus option of the elastomeric pump. This event will be documented and recorded with the time of occurrence in a mobile application developed for this purpose.

Study contacts

Contact information is provided by the study sponsor or research team.

Fernando R Altermatt, MD

CONTACT

[email protected]

56955049115 ext. 9115

Victor Contreras, MSN

CONTACT

[email protected]

56223543414 ext. 3414

Sponsors and collaborators

Lead sponsor

Pontificia Universidad Catolica de Chile

Other

Registry information

Official study title

Comparison of Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery: A Randomized Study Assessing Non-inferiority and Superiority (CORA-Q15)

Acronym: CORA-Q15

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jan 1, 2025
Registry last updated
May 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.